Stock Research for APNHF

APNHF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

APNHF Stock Chart & Research Data

The APNHF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APNHF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APNHF Due diligence Resources & Stock Charts

The APNHF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APNHF Detailed Price Forecast - CNN Money CNN View APNHF Detailed Summary - Google Finance
Yahoo View APNHF Detailed Summary - Yahoo! Finance Zacks View APNHF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View APNHF Trends & Analysis - Trade-Ideas Barrons View APNHF Major Holders - Barrons
NASDAQ View APNHF Call Transcripts - NASDAQ Seeking View APNHF Breaking News & Analysis - Seeking Alpha
Spotlight View APNHF Annual Report - CompanySpotlight.com OTC Report View APNHF OTC Short Report - OTCShortReport.com
TradeKing View APNHF Fundamentals - TradeKing Charts View APNHF SEC Filings - Bar Chart
WSJ View Historical Prices for APNHF - The WSJ Morningstar View Performance/Total Return for APNHF - Morningstar
MarketWatch View the Analyst Estimates for APNHF - MarketWatch CNBC View the Earnings History for APNHF - CNBC
StockMarketWatch View the APNHF Earnings - StockMarketWatch MacroAxis View APNHF Buy or Sell Recommendations - MacroAxis
Bullish View the APNHF Bullish Patterns - American Bulls Short Pains View APNHF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View APNHF Stock Mentions - StockTwits PennyStocks View APNHF Stock Mentions - PennyStockTweets
Twitter View APNHF Stock Mentions - Twitter Invest Hub View APNHF Investment Forum News - Investor Hub
Yahoo View APNHF Stock Mentions - Yahoo! Message Board Seeking Alpha View APNHF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for APNHF - SECform4.com Insider Cow View Insider Transactions for APNHF - Insider Cow
CNBC View APNHF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APNHF - OTC Markets
Yahoo View Insider Transactions for APNHF - Yahoo! Finance NASDAQ View Institutional Holdings for APNHF - NASDAQ


Stock Charts

FinViz View APNHF Stock Insight & Charts - FinViz.com StockCharts View APNHF Investment Charts - StockCharts.com
BarChart View APNHF Stock Overview & Charts - BarChart Trading View View APNHF User Generated Charts - Trading View




Latest Financial News for APNHF


Drugmaker Aspen sells baby milk business to dairy giant Lactalis
Posted on Thursday September 13, 2018

Aspen Pharmacare (APNJ.J) has agreed to sell its infant formula business to Lactalis for 12.9 billion rand (660.64 million pounds) to focus on core activities while the French buyer looks to revive its baby milk expansion after a health scandal. The company's share price tumbled after the deal's announcement on Thursday alongside full-year earnings, dropping 26 percent before paring losses to stand 16.3 percent down at 228.06 rand by 1430 GMT. Rising incomes in emerging markets coupled with global population growth have made infant formula an attractive proposition in a market dominated by Nestle (NESN.S), Danone (DANO.PA) and Reckitt Benckiser (RB.L), which acquired Mead Johnson of the United States last year.


South Africa's Aspen sells infant formula business to Lactalis for $865 million
Posted on Thursday September 13, 2018

African drugmaker Aspen Pharmacare (APNJ.J) has agreed to sell its infant formula business to French dairy group Lactalis for 12.9 billion rand ($865 million), looking to capitalise on the sector's recent flurry of dealmaking to reduce its debt and focus on core operations. Shares in Aspen dropped more than 9 percent to 245.85 rand after Africa's biggest manufacturer of generic drugs announced the deal as it reported full-year earnings. Rising incomes in emerging markets coupled with global population growth have made infant formula an attractive proposition in a market dominated by Nestle (NESN.S), Danone (DANO.PA) and Reckitt Benckiser (RB.L), which acquired Mead Johnson of the United States last year.


French Billionaire Cheese King Eyes China Baby-Food Market
Posted on Wednesday September 12, 2018

Lactalis International agreed to buy an infant-formula business from Aspen Pharmacare Holdings Ltd. for 740 million euros ($860 million) as the world’s biggest cheese maker targets the fast-growing Chinese baby-food market. The move will enable the company run by French billionaire Emmanuel Besnier to tap rising demand for baby food in Asia’s biggest economy following the scrapping of its one-child policy around 2016. For Aspen’s part, the sale will enable Africa’s biggest drugmaker to focus on its main pharmaceutical operations, the Durban, South Africa-based company said in a statement on Thursday.


Deals of the day-Mergers and acquisitions
Posted on Tuesday September 11, 2018

(Adds Aspen, Iliad, ArcelorMittal, Hudson's Bay, Elementis, updates Alibaba) Sept 11 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Tuesday: ** Aspen Pharmacare ...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.